A case of severe acalculous cholecystitis associated with sorafenib treatment for advanced hepatocellular carcinoma

Sorafenib, a multikinase inhibitor, is the first and only drug, which improves significantly the overall survival in patients with advanced hepatocellular carcinoma (HCC). However, many patients experience diverse side effects, some of them severe and unexpected. To date, acute acalculous cholecysti...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Aihara, Yosuke, Yoshiji, Hitoshi, Yamazaki, Masaharu, Ikenaka, Yasuhide, Noguchi, Ryuichi, Morioka, Chie, Kaji, Kosuke, Tastumi, Haruki, Nakanishi, Keisuke, Nakamura, Maiko, Yamao, Junichi, Toyohara, Masahisa, Mitoro, Akira, Sawai, Masayoshi, Yoshida, Motoyuki, Fujimoto, Masao, Uemura, Masahito, Fukui, Hiroshi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Baishideng Publishing Group Co., Limited 2012
Aiheet:
Case Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3360105/
https://ncbi.nlm.nih.gov/pubmed/22645635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v4.i5.115
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia